SSPC are delighted to report that registration is now open for the 2023 Long-Acting Injectables Conference. Advances in manufacturing and monitoring suspension-based LAIs. February, 8-9, 2023 Antwerp, Belgium.
Check out our full schedule and pick up your ticket today to ensure your seat is reserved. We look forward to seeing you at this exciting and inspiring event including with inputs and discussion on Top-down approaches: are they to stay? Panel discussion, Milling API: Challenges and Future perspectives, Production, stabilization and scale-up of LAIs via antisolvent process: the case of indomethacin, PAT in a modern world, 20Overview of online and at-line Material Characterization Technologies for Manufacturing of Pharmaceutical Drug Substances and Drug Products and much more…..
See the full line up of speakers and register today at https://www.eventbrite.ie/e/2023-long-acting-injectables-conference-tickets-425181859387. Website: https://laiconference.wixsite.com/2023
DAY 1 – 8th Feb 2023
09.00 – 09.05 – Opening Remarks
09.05 – 09.50 Long-acting injectables: The Highway to Effective Treatment – René Holm, University of Southern Denmark
09.50 – 10.35 Milling API: Challenges and Future perspectives – Noor Al-Rifai,The Janssen Pharmaceutical Companies of Johnson & Johnson
10.35 – 11.00 Coffee-break
11.00 – 11.30 Production, stabilization and scale-up of LAIs via antisolvent process: the case of indomethacin – Mariana Silva, The Janssen Pharmaceutical Companies of Johnson & Johnson
11.30 – 12.00 A comparative study of dry and wet top-down approaches for the preparation of microsuspensions – Fidel Mendéz, University of Limerick
12.00 – 12.15 Top-down approaches: are they to stay? Panel discussion
12.15 – 13.15 Lunch / Poster session
13.15 – 14.00 Biocrystallisation for the Process Intensification of Downstream Bioprocessing for Peptides and Proteins – Jerry Heng, Imperial College London
14.00 – 14.30 Influence of particle size on API solubility: a modelling approach -Amábille Kloc, TU Dortmund
14.30 – 15.00 PM Fate of Excipients during solvent switch of API crystalline suspension for Long-Acting Injectables – Fatima Anjum, TU Dortmund
15.00 – 15.30 Afternoon tea
15.30 – 16.00 Continuous bottom-up manufacturing: A sustainable framework for long-acting injectables – Snehashis Nandi, The Janssen Pharmaceutical Companies of Johnson & Johnson
16.00 – 16.40 Long-acting injectables in a global public health perspective – Carmen Pérez Casas, Unitaid
16.40 – 16.55 Closing Remarks. 19.00 – Social Dinner
DAY 2 – 9th Feb 2023
9.00 – 9.05 Opening Remarks
9.05 – 9.50 PAT in a modern world – Mario Hellings, The Janssen Pharmaceutical Companies of Johnson & Johnson
9.50 – 10.20Overview of online and at-line Material Characterization Technologies for Manufacturing of Pharmaceutical Drug Substances and Drug Products – Steve Ward-Smith, Malvern Pananalytical
10.20 – 10.50 Using Raman Spectroscopy to measure particle size of APIs in concentrated nanosuspensions – Alan Ryder, University of Galway
10.50 – 11.20 Coffee-break
11.20 – 11.50 Spatially Resolved Dynamic Light Scattering: adding a new dimension to real time monitoring of nanomilling processes – Carl Schuurmans, IP-LSP
11.50 – 12.20 Combination of online laser diffraction and SR-DLS – towards real time process monitoring of pharmaceutical drug production processes – Nicole Meulendijks, TNO
12.20 – 13.30 Lunch / Poster session
13.30 – 14.00 PAT monitoring during sterile top-down manufacturing of an aqueous microsuspension – Maxim Verstraeten, The Janssen Pharmaceutical Companies of Johnson & Johnson
14.00 – 14.30 PAT tools: how are they changing manufacturing? – Panel discussion
14.30 – 14.45 Closing Remarks
